You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Pelvic Prolapse1 Apr 2016MP10-16 LONG-TERM EFFICACY AND PATIENT SATISFACTION OF PELVIC ORGAN PROLAPSE REDUCTION USING TRANSVAGINAL MESH Melanie Aube-Peterkin, Marilyne Guerin, Tina McVeigh, Caroline Rheaume, and Le Mai Tu Melanie Aube-PeterkinMelanie Aube-Peterkin More articles by this author , Marilyne GuerinMarilyne Guerin More articles by this author , Tina McVeighTina McVeigh More articles by this author , Caroline RheaumeCaroline Rheaume More articles by this author , and Le Mai TuLe Mai Tu More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.2346AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The Food and Drug Association (FDA), as well as Health Canada, have published warnings concerning the safety of transvaginal mesh for pelvic organ prolapse (POP) surgery due to the risk of mesh-related adverse events, without increased efficacy when compared to non-mesh POP repair. Our objective is to present our centers’ data on POP surgery using transvaginal mesh, focusing on recurrence and complication rates, as well as patient subjective satisfaction. METHODS We reviewed the charts of all patients who underwent POP surgery in two university-affiliated hospitals, between 2000 and 2013. Patients were contacted for a long-term follow-up clinic, consisting of a questionnaire and a gynecological exam. Patients who declined to travel for follow-up had the option to answer the questionnaire via phone. Collected information included patient baseline characteristics, type of surgery and mesh used, gynecological exam using the Simplified POP Quantification System (S-POPQ), and patient subjective satisfaction using the Patient Global Impression of Improvement (PGI-I) validated questionnaire. RESULTS 118 patients agreed to visit the long-term follow-up clinic, and 28 agreed to answer the questionnaire via telephone (total 146). At baseline, 125 patients (85%) presented with multiple compartment POP, and 86 patients (58.9%) with high grade POP (grade = 3). The most frequent types of mesh used were: Prolift (49.3%), Exair (22.6%), Avaulta (6.8%) and Elevate (6.2%). Median follow-up was 61 (24-154 months) for questionnaire and 60 months (24-157 months) for physical exam. 21 (18%) of the examined patients presented with clinically significant (grade = 2) recurrent POP of a previously mesh-treated compartment. Of these patients, 2 were symptomatic, but did not require repeat surgery. 13 patients (11%) suffered from mesh extrusion. Only 3 of these 13 patients were symptomatic. 9 of these 13 patients required surgical mesh revision for their extrusion. 2 patients suffered from chronic pelvic pain. 7 patients reported dyspareunia. 142 (97.3%) of patients reported that they were improved by their surgery (PGI-I score of 1-3). CONCLUSIONS At long-term follow-up, patients with trans-vaginal mesh repair of POP have low complication and reoperation rates, and are subjectively improved by their surgery. Trans-vaginal mesh remains a safe and effective option for the treatment of POP. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e108 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Melanie Aube-Peterkin More articles by this author Marilyne Guerin More articles by this author Tina McVeigh More articles by this author Caroline Rheaume More articles by this author Le Mai Tu More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...